Megakaryocytes are large, specialized cells found in the bone marrow, responsible for the production of platelets, essential components involved in blood clotting and coagulation. These unique cells undergo a process called thrombopoiesis, where they give rise to platelets through fragmentation of their cytoplasm. Megakaryocytes are characterized by their large size, multilobulated nuclei, and abundant cytoplasmic granules. The regulation of megakaryocyte development and platelet production is tightly controlled by various growth factors, including thrombopoietin. As megakaryocytes mature, they extend long cytoplasmic projections, known as proplatelets, into the bone marrow sinusoids, facilitating the release of platelets into the bloodstream. The intricate balance between megakaryocyte proliferation and platelet release is crucial for maintaining proper hemostasis and preventing excessive bleeding or clotting disorders. Dysregulation of megakaryocyte function is implicated in various hematological conditions, such as thrombocytopenia or myeloproliferative disorders. Understanding the biology of megakaryocytes is vital for deciphering the mechanisms governing platelet production and thrombopoiesis. Ongoing research in hematology aims to uncover the molecular pathways involved in megakaryocyte maturation and platelet release, paving the way for potential therapeutic interventions in bleeding and clotting disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy